Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von PlusUltra 

Taro Pharmaceutical Industries Ltd diskutieren

Taro Pharmaceutical Industries Ltd

WKN: 897505 / Symbol: TARO / Name: Taro Pharm / Aktie / Pharmazeutika / Mid Cap /

39,00 €
-

Einschätzung Sell
Rendite (%) 10,25 %
Kursziel 85,69
Veränderung
Endet am 12.07.17

TARO

Einschätzung Sell
Rendite (%) 10,25 %
Kursziel 85,69
Veränderung
Endet am 12.07.17

(Laufzeit überschritten)

Einschätzung Buy
Rendite (%) 1,84 %
Kursziel 117,26
Veränderung
Endet am 16.07.18

130

Einschätzung Buy
Rendite (%) 1,84 %
Kursziel 117,26
Veränderung
Endet am 16.07.18

(Laufzeit überschritten)

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for TARO provided by MarketBeat

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Ratings data for TARO provided by MarketBeat

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for TARO provided by MarketBeat

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for TARO provided by MarketBeat

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for TARO provided by MarketBeat

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for TARO provided by MarketBeat

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for TARO provided by MarketBeat

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Ratings data for TARO provided by MarketBeat